Related Experiment Video
Updated: Mar 17, 2026
Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
[Study on the Inhibitory Effect and Mechanism of Trans-2-Decenal on Helicobacter pylori in vitro]
Lei He1, Qiyunna He1, Haiying Tian1
1/ （ 610041）West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu 610041, China.
Objective:
To investigate the in vitro inhibitory and bactericidal activities of the trans-2-decenal compound against Helicobacter pylori (H. pylori) and explore its potential mechanism.
Methods:
The minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) of trans-2-decenal against H. pylori clinical isolates and the standard strain ATCC43504 were determined using the broth microdilution method. Changes in MIC values were monitored to assess drug resistance in H. pylori induced by continuous treatment with trans-2-decenal. The synergistic antibacterial effect of combining trans-2-decenal with antibiotics such as metronidazole (MTZ), clarithromycin (CLA), amoxicillin (AMX), and levofloxacin (LEV) was evaluated using the fractional inhibitory concentration index (FICI). After treating standard H. pylori strains with trans-2-decenal, scanning electron microscopy, transmission electron microscopy, crystal violet staining, the semi-solid puncture method, and the Berthelot method were used to assess the effects of trans-2-decenal on the morphology, cell structure, migration, and urease activity of H. pylori.
Results:
The MIC range for clinically resistant H. pylori strains C907, C101, R1, R2, R4, R10, R16, R24, R36, and R40 was 8-16 μg/mL, with an MBC range of 16-32 μg/mL. The MIC for the H. pylori standard strain ATCC43504 was 16 μg/mL, with an MBC of 16 μg/mL.Trans-2-decenal inhibits H. pylori at low concentrations for short durations and does not easily induce H. pylori resistance. Trans-2-decenal reduces the required dosage of antibiotics (metronidazole and levofloxacin), showing an additive effect. Trans-2-decenal alters the shape of H. pylori and promotes bacterial rupture. Furthermore, Trans-2-decenal exerts its effects by altering H. pylori morphology, inducing bacterial rupture, inhibiting biofilm formation, reducing the number of mature biofilms, and decreasing urease activity and H. pylori migration ability.
Conclusion:
Trans-2-decenal may inhibit H. pylori in vitro through multiple mechanisms and is unlikely to promote the development of H. pylori resistance.
More Related Videos
Related Concept Videos
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
01:28Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
01:13Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
01:22Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
01:28Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.